Clinical Trials of Novel Targeted Therapies in Ovarian Cancer: Moving Beyond Poly ADP Ribose Polymerase (PARP) Inhibitors
Quan Guo(Hunan University of Science and Engineering), Steve Jia(Pacific Biosciences (United States)), Guipeng Liu(Lanzhou University), Igor Nikoulin, Jun Li(Hubei Polytechnic University), Qing Yang(China Medical University)
Cited by 6
Related Papers
Expression of bone morphogenetic protein-2 and its receptors in epithelial ovarian cancer and their influence on the prognosis of ovarian cancer patients
|Journal of Experimental & Clinical Cancer Research|2010|115
Autophagy is activated in the ovarian tissue of polycystic ovary syndrome
|Reproduction|2017|98
Pre-Eclampsia-Associated Reduction in Placental Growth Factor Impaired Beta Cell Proliferation Through PI3k Signalling
|Cellular Physiology and Biochemistry|2015|14